KLP Kapitalforvaltning’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.16M Hold
21,400
0.02% 501
2026
Q1
$4.05M Buy
21,400
+900
+4% +$157K 0.02% 528
2025
Q4
$3.48M Sell
20,500
-2,200
-10% -$337K 0.01% 556
2025
Q3
$2.99M Sell
22,700
-1,100
-5% -$132K 0.01% 572
2025
Q2
$2.53M Buy
23,800
+6,500
+38% +$706K 0.01% 588
2025
Q1
$2.15M Buy
17,300
+300
+2% +$39.1K 0.01% 627
2024
Q4
$2.09M Buy
+17,000
New +$2M 0.01% 650

Other funds holding JAZZ

KLP Kapitalforvaltning's JAZZ Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 21,400 shares worth $5.16M. The position accounts for 0.02% of the portfolio, ranked #501.

KLP Kapitalforvaltning first reported a position in JAZZ in Q4 2024 and has held it in 7 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • KLP Kapitalforvaltning held 21,400 shares of Jazz Pharmaceuticals worth $5.16M as of Q2 2026.
  • KLP Kapitalforvaltning left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.02% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #501 holding.
  • KLP Kapitalforvaltning first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.